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Ketol-acid reductoisomerase (EC 1.1.1.86) catalyses the second
reaction in the biosynthesis of branched-chain amino acids. The
reaction involves an Mg2+-dependent alkyl migration followed by an
NADPH-dependent reduction of the 2-keto group. Here, the
crystallization of the Escherichia coli enzyme is reported. A form
with a C-terminal hexahistidine tag could be crystallized under 18
different conditions in the absence of NADPH or Mg2+ and a further
six crystallization conditions were identi®ed with one or both ligands.
With the hexahistidine tag on the N-terminus, 20 crystallization
conditions were found, some of which required the presence of
NADPH, NADP+, Mg2+ or a combination of ligands. Finally, the
selenomethionine-substituted enzyme with the N-terminal tag
crystallized under 15 conditions. Thus, the enzyme is remarkably
easy to crystallize. Most of the crystals diffract poorly but several data
sets were collected at better than 3.2 AÊ resolution; attempts to phase
them are currently in progress.
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1. Introduction
Ketol-acid reductoisomerase (KARI; EC
1.1.1.86; reviewed by Dumas et al., 2001) cata-
lyzes the second reaction in the biosynthesis of
branched-chain amino acids, converting either
2-hydroxy-3-keto-2-methylbutyrate (aceto-
lactate) or 2-hydroxy-3-keto-2-ethylbutyrate to
the corresponding 2,3-dihydroxy-3-alkylbuty-
rate. The reaction occurs in two stages
(Chunduru et al., 1989; Dumas et al., 1995)
involving an Mg2+-dependent alkyl migration
to form a 3-hydroxy-2-keto-3-alkylbutyrate
intermediate followed by an Mg2+-, Mn2+- or
Co2+-dependent reduction of the 2-keto func-
tion by NADPH. Since the biosynthetic
pathway is absent in animals, but present in
microorganisms and plants, KARI is a poten-
tial target for both antimicrobial compounds
and herbicides. Inhibitors have been developed
(Schulz et al., 1988; Aulabaugh & Schloss,
1990) as possible herbicides but have not
proved to be very active towards plants
(Dumas et al., 1994).
Ahn et al. (2003) have grouped KARI
proteins into two classes: class I enzymes
contain 330±340 amino-acid residues, while
class II have lengths of 490 residues because
of an extra segment near the middle of the
protein. Class I KARIs are typically found in
microorganisms, while class II KARIs are
characteristic of plants. However, there are
scattered exceptions amongst the -proteo-
bacteria, including Escherichia coli, which
contains a class II KARI (Ahn et al., 2003).
Three-dimensional structures of both class I
(Pseudomonas aeruginosa; Ahn et al., 2003)
and class II (spinach; Biou et al., 1997;
Thomazeau et al., 2000) KARIs have been
published. The middle and C-terminal domains
of spinach KARI spatially overlap the
C-terminal domains of a pair of P. aeruginosa
KARI monomers. As a result, the active site of
spinach KARI is contained entirely within a
monomer, whilst that of P. aeruginosa KARI is
made up of residues from two monomers.
Notwithstanding this radically different orga-
nization, almost all active-site residues are
conserved spatially.
The three-dimensional structure of class II
bacterial KARI has yet to be solved and we
have therefore attempted to crystallize the
E. coli enzyme. The protein proved to be
remarkably easy to crystallize and a variety of
distinct forms were obtained readily.
2. Materials and methods
2.1. Materials
Materials were purchased from the
following common commercial suppliers.
Crystal Screens (1, 2, Lite, Ammonium Sulfate,
PEG/LiCl, PEG 6000 and Natrix) were from
Hampton Research and Wizard crystal screens
were from Emerald Biostructures.
2.2. Protein expression and purification
E. coli KARI with an N-terminal hexahisti-
dine tag, hereafter denoted N-KARI, was
expressed as described previously (Hill &
Duggleby, 1999). To express the protein with a
C-terminal hexahistidine tag (C-KARI), a new
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construct was developed in which the
protein has a native N-terminus and a C-
terminus to which is added the sequence
LEHHHHHH. To obtain the seleno-
methionine-substituted protein, expression
was performed by a method similar to that
described by Thomazeau et al. (2001). The
enzymes were puri®ed as described
previously and stored at 203 K in 20 mM Na
HEPES buffer pH 7.5, except that for SeMet
KARI puri®cation buffers were degassed
just prior to puri®cation, fractions (4 ml)
were collected in tubes containing 1 ml 1 M
DTT and the enzyme was stored in buffer
supplemented with 1 mM DTT and 0.2 mM
Na EDTA.
2.3. Crystallization
Crystals were obtained using the hanging-
drop vapour-diffusion method. Various
crystallization conditions were initially
identi®ed using commercial screens. Trials
were carried out at 291 K in 24-well plates
containing 500 ml screen reagent and drops
formed by mixing 3 ml each of well reagent
and protein (5±15 mg mlÿ1).
2.4. X-ray data collection
All the KARI crystals were mounted
either in a quartz capillary tube for room-
temperature data collection or in a nylon
loop that was cryocooled in a liquid-nitrogen
stream (Oxford Cryosystems Cryostream).
For cryocooling, the crystals were trans-
ferred to an appropriate solution that varied
for different crystals. Before freezing, some
crystals were dehydrated by placing the drop
containing the crystals over a reservoir with
progressively higher (20±30% in steps of
5%) precipitant concentrations (Heras et al.,
2003).
For the N-KARI crystals, preliminary
screening of crystals was performed using an
R-AXIS IV++ image-plate detector and a
Rigaku RU-200 generator at the University
of Queensland. Data sets were collected at
ESRF (Grenoble, France) on beamlines
BM14 and ID14-3 and at the Advanced
Photon Source, Argonne National Labora-
tory, Chicago, USA with an ADSC Q4 CCD
detector on beamlines 14ID-B (MAD) or
14ID-D (all other data). The N-KARI data
were integrated with DENZO and scaled
and merged with SCALEPACK (Otwi-
nowski & Minor, 1997). A complete data set
for C-KARI in complex with NADPH was
collected using an FR-E X-ray generator
operated at 45 kV and 45 mA and an
R-AXIS IV++ image-plate area detector at
the University of Queensland. The images
were scaled and merged using the Crystal-
Clear v.1.3.5 software (Rigaku/MSC, Texas,
USA; P¯ugrath, 1999).
3. Results and discussion
3.1. Protein expression and purification
The speci®c activity of C-KARI
(1.2 U mgÿ1) is comparable to that of
N-KARI (1.5 U mgÿ1). Selenomethionine-
substituted N-KARI has a speci®c activity of
1.3 U mgÿ1 and the incorporation of sele-
nomethionine was 91% as determined by
amino-acid analysis.
3.2. Crystallization
E. coli KARI proved to be exceptionally
easy to crystallize using commercial formu-
lations. Some formulations were varied to
improve the crystals. C-KARI crystallized
under 18 different conditions in the absence
of added active-site ligands and three
formulations that contained the Mg2+ cation
cofactor (see Table A in the supplementary
Figure 1
Crystals obtained under various conditions reported in supplementary material Table A. Row 1, left to right:
conditions 4 [C-KARI with 5%(w/v) PEG 6000, 0.1 M sodium citrate pH 5.0], 6 [C-KARI with 10%(v/v)
isopropanol, 10%(w/v) PEG 4000, 0.1 M sodium citrate pH 5.6] and 19 [C-KARI with 10%(w/v) PEG 3000, 0.2 M
MgCl2, 0.1 M sodium cacodylate pH 6.5]; row 2, 16 [C-KARI with 20%(w/v) PEG 6000, 0.1 M Na Bicine pH 9.0],
20 [C-KARI with 20%(w/v) PEG 1000, 0.2 M MgCl2, 0.1 M sodium cacodylate pH 6.5] and 54 [SeMet-N-KARI
with 15%(w/v) PEG 4000, 0.2 M Li2SO4, 0.1 M Tris±HCl pH 8.5]; row 3, 22 [C-KARI with NADPH, 10%(w/v)
PEG 8000, 0.2 M NaCl, 0.1 M sodium/potassium phosphate pH 6.2], 24 [C-KARI with NADPH, 10%(w/v) PEG
3000, 0.2 M MgCl2, 0.1 M sodium cacodylate pH 6.5] and 35 [N-KARI with NADPH, 30%(v/v) PEG MME 550,
0.1 M NaCl, 0.1 M Na Bicine pH 9.0]; row 4, 23 [C-KARI with NADPH, 1.6 M (NH4)2SO4, 0.1 M Na Bicine pH
9.0], 26 [N-KARI with 10%(w/v) PEG 6000, 4.8%(v/v) MPD, 0.1 M Na HEPES pH 7.5] and 33 [N-KARI with
NADPH, 0.68 M trisodium citrate, 0.1 M Tris±HCl pH 8.5]; row 5, 27 [N-KARI with 15%(w/v) PEG 4000, 0.2 M
sodium acetate, 0.1 M Tris±HCl pH 8.5], 45 [SeMet-N-KARI with 20%(w/v) PEG 3000, 0.1 M sodium citrate pH
5.5] and 55 [SeMet-N-KARI with 15%(w/v) PEG 4000, 0.2 M sodium acetate, 0.1 M Tris±HCl pH 8.5].
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material). Crystals of N-KARI were
obtained with no added ligands, with added
Mg2+, NADPH or NADP+ and with combi-
nations of these ligands (see Table A in
supplementary material). SeMet-N-KARI
also crystallized under a range of conditions
(see Table A in the supplementary material);
no trials were undertaken with ligands,
except for Mg2+, which is present in two of
the formulations. Some of the crystals
obtained are illustrated in Fig. 1.
Paradoxically, although crystals were
obtained easily, conditions that yielded high-
resolution diffraction data were dif®cult to
®nd. There was a bewildering array of
starting conditions to choose for optimiza-
tion and many of these led to crystals with an
attractive appearance but that diffracted to
only 4 AÊ resolution or weaker. The crystals
showed a wide range of unit-cell parameters
and space groups (see Table B in the
supplementary material ). Re¯ection data
collected to better than 3.2 AÊ were obtained
from crystals grown under conditions 23, 27
and 55 (see Table 1). For SeMet-N-KARI
(condition 55), we commenced collection of
a MAD data set, but degradation of the
crystal allowed only limited information to
be obtained at the third wavelength.
3.3. Diffraction data
Two data sets for KARI have been
obtained at better than 3.0 AÊ resolution,
with the best being the C-KARI crystals
obtained from condition 23, which diffract to
2.6 AÊ resolution. On the basis that the
Matthews coef®cient is in the normal range
for proteins (Matthews, 1968), there appear
to be six monomers in the asymmetric unit.
Attempts to phase data sets by molecular
replacement with CNS (BruÈ nger et al., 1998)
and AMoRe (Navaza, 1994) using various
models based on parts of spinach or
P. aeruginosa KARI failed to identify the
correct solutions. Using the data obtained
for the best selenomethionine-substituted
N-KARI crystals, the programs CNS
(BruÈ nger et al., 1998), SnB (Weeks & Miller,
1999) and SOLVE (Terwilliger &
Berendzen, 1999) have not been able to
clearly identify the locations of the Se atoms.
New attempts at molecular replacement
using the program EPMR (Kissinger et al.,
1999) are now under way.
4. Conclusions
KARI is an easy protein to crystallize.
Unfortunately, the resolution of data
obtained for the majority of these crystals is
worse than 3.0 AÊ , suggesting that while there
are some good contacts leading to crystal-
lization, there are insuf®cient contacts to
highly order the majority of the protein and
tag atoms in these crystals. Once the crystal
structures begin to emerge, E. coli KARI
will provide an interesting case study to
observe the structural features that lead to
its ease of crystallization.
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Table 1
Diffraction data for E. coli KARI.
Values in parentheses are statistics for the outer resolution shell: 2.69±2.60 AÊ for condition 23 [C-KARI with NADPH,
1.6 M (NH4)2SO4, 0.1 M Na Bicine pH 9.0], 3.0±2.9 AÊ for condition 27 [N-KARI with 15%(w/v) PEG 4000, 0.2 M sodium
acetate, 0.1 M Tris±HCl pH 8.5] and 3.30±3.15 AÊ for condition 55 [SeMet-N-KARI with 15%(w/v) PEG 4000, 0.2 M
sodium acetate, 0.1 M Tris±HCl pH 8.5].
Condition 23 27 55
Temperature (K) 100 100 100
Resolution (AÊ ) 32.48±2.60 100±2.90 100±3.15
No. observations 922387 (62352) 166739 (6902) 352826 (5685)
Unique re¯ections 106858 (10489) 54141 (3441) 43994 (3155)
Completeness (%) 99.8 (98.5) 89.3 (57.5) 91.4 (47.4)
hI/(I)i 20.9 (5.1) 11.3 (6.0) 7.1 (2.5)
Rsym² 0.074 (0.300) 0.099 (0.187) 0.088 (0.153)
² Rsym =
P jI ÿ hIij=PhIi.
1 Supplementary material has been deposited in
the IUCr electronic archive (Reference TS5013).
Details for accessing these data are described at
the back of the journal.
